Skip to contentJ
JRSIS HEALTH CARE Corp
J
JRSSJRSIS HEALTH CARE Corp Q2 2021 · 10-Q
Revenue$11.74M$11.74M+67.3% vs Q2 2020 Net Income$1.02M$1.02M+153.8% vs Q2 2020 EPS Diluted$0.06$0.06+242.4% vs Q2 2020 Operating Income-$1,515N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,922,985+280.2% Margins · derivedOperating margin-0.0%−9.3 pt vs Q2 2020
Net margin8.7%+3.0 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 20, 2021 · 51 d after period end